High-dose valacyclovir to prevent congenital cytomegalovirus transmission in pregnancy: is it possible to reduce major side effects?

Ultrasound Obstet Gynecol. 2023 Apr;61(4):539-540. doi: 10.1002/uog.26193.

Authors

M De Santis^{1

2}, T G Vitelli², R Santangelo^{2

3}, A Lanzone^{1

2}, S Tartaglia¹

Affiliations

¹ Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento Scienze della Salute della Donna e del Bambino e di Sanità Pubblica, Rome, Italy.
² Università Cattolica del Sacro Cuore, Milan, Italy.
³ Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento Scienze di Laboratorio e Infettivologiche, Rome, Italy.

PMID: 37011081
DOI: 10.1002/uog.26193

No abstract available

Publication types

Letter

MeSH terms

Antiviral Agents* / administration & dosage
Cytomegalovirus
Cytomegalovirus Infections* / prevention & control
Female
Humans
Iatrogenic Disease
Infectious Disease Transmission, Vertical* / prevention & control
Pregnancy
Pregnancy Complications, Infectious* / drug therapy
Pregnancy Complications, Infectious* / prevention & control
Valacyclovir* / administration & dosage

Substances

Antiviral Agents
Valacyclovir